The Market For Normal Balloon Catheters Is Expected To Surge At 7% CAGR From 2021-2031

As per Fact.MR, a market research and competitive intelligence provider, the global market for normal balloon catheters was valued at US$ 1.8 Bn in 2020. Surge in interventional cardiology has been facilitating the utilization of normal balloon catheters. Moreover, there is a rise in the prevalence of patients affected with end-stage renal disease.

The number of patients seeking renal replacement therapy has also increased. Leading manufacturers of catheter devices are developing efficient and cost-effective solutions. These incidences might influence the growth of the global normal balloon catheter market over the coming years. In addition, various other factors such as the growing geriatric population, rising investments in research & development activities concerning normal balloon catheters are expected to boost the demand for balloon catheters.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:https://www.factmr.com/connectus/sample?flag=S&rep_id=147

𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀 𝗙𝗮𝗰𝗲𝗱 𝗯𝘆 𝗡𝗼𝗿𝗺𝗮𝗹 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗲𝗿𝘀?

Costs of angioplasty procedures are very high, coupled with risks such as artery collapse and infection related to balloon catheterization, which, in turn, will impede the sales of catheter devices to some extent.
Stringent regulatory authorities and choice of alternatives such as bypass surgery are likely to hinder growth of the overall catheter market.

𝗪𝗵𝗶𝗰𝗵 𝗥𝗲𝗴𝗶𝗼𝗻 𝗶𝘀 𝗧𝘂𝗿𝗶𝗻𝗴 𝗢𝘂𝘁 𝘁𝗼 𝗕𝗲 𝗮 𝗟𝘂𝗰𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗳𝗼𝗿 𝗡𝗼𝗿𝗺𝗮𝗹 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗲𝗿𝘀?

In terms of revenues, Europe will account for the largest share of the market during the forecast period. Revenue in the European regional market is set to grow 1.4X by 2031.
Increase in patient awareness, simple access to innovative healthcare services, and growing demand for advanced balloon catheters are factors to consider for market growth in the region.
Focus on government spending, particularly in research & development by major players, are expected to fuel demand for normal balloon catheters in ambulatory surgical centers.
Growing demand for polyurethane normal balloon catheters in Canada and rising opportunities for manufacturers of normal balloon catheters in Japan are all making a significant contribution to global market growth prospects for normal balloon catheters.

𝗪𝗵𝘆 𝗮𝗿𝗲 𝗡𝘆𝗹𝗼𝗻 𝗡𝗼𝗿𝗺𝗮𝗹 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿𝘀 𝗚𝗮𝗶𝗻𝗶𝗻𝗴 𝗜𝗺𝗺𝗲𝗻𝘀𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝗿𝗶𝘁𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗠𝗮𝗿𝗸𝗲𝘁?

Based on raw material, nylon will remain sought-after among manufacturers of normal balloon catheters. Approximately half the market share will be held by nylon normal balloon catheter sales during the forecast period. Sales of nylon-based normal balloon catheters are expected to increase 2.1X over the forecast period.
This is mostly due to the advantages of using nylon as a raw material in these devices, as nylon is softer, easier to refold, and easier to withdraw into the guiding catheter or introducer sheath.
As compared to PET (polyethylene terephthalate) variants, nylon high-pressure balloons need a thicker wall for a given burst pressure, which indicates that when inserted into the body and across a lesion, so the demand for nylon normal balloon catheters is more than PET balloon catheters.

𝗪𝗵𝘆 𝗶𝘀 𝗗𝗲𝗺𝗮𝗻𝗱 𝗳𝗼𝗿 𝗡𝗼𝗿𝗺𝗮𝗹 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿𝘀 𝗳𝗿𝗼𝗺 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹𝘀 𝗛𝗶𝗴𝗵?

Sales of normal balloon catheters for hospitals are expected to exhibit fastest expansion through 2031, based on end user. Hospitals will remain the largest end users of normal balloon catheters throughout the forecast period.
Growth of this segment is being driven by growing incidence of chronic diseases and rising demand for efficient and effective surgery with shorter recovery times and shorter hospital stays.
Availability of advanced technologies as well as requirement for minimally invasive surgical procedures are both driving demand for normal balloon catheters in hospitals.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:https://www.factmr.com/connectus/sample?flag=RC&rep_id=147

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Several normal balloon catheter manufacturing companies have implemented merger and acquisition plans to differentiate them as prominent competitors in the market and to increase sales in the worldwide normal balloon catheter market.
PTA balloon manufacturing companies are forming alliances with small businesses to improve their product portfolios and extend their worldwide footprints. Launch of new products is another method used by manufacturers of normal balloon catheters to increase their market share and domination.

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱:

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• MicroPort Scientific Corporation
• B. Braun Melsungen AG
• Meril Life Sciences Pvt. Ltd.
• Hexacath
• Tokai Medical Products Inc.
• Cook Medical INC
• Cordis Corporation
• BIOTRONIK SE & Co. KG.

𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝗡𝗼𝗿𝗺𝗮𝗹 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

Raw Material
• Polyurethane Normal Balloon Catheters
• Nylon Normal Balloon Catheters
• Others

Indication
• Normal Balloon Catheters for Coronary Artery Disease
• Normal Balloon Catheters for Peripheral Vascular Disease
• Normal Balloon Catheters for Preventing Blood Vessel Constriction
• Normal Balloon Catheters for Percutaneous Coronary Intervention
• Others

End User
• Normal Balloon Catheters for Hospitals
• Normal Balloon Catheters for Ambulatory Surgical Centers
• Normal Balloon Catheters for Cardiac Catheterization Laboratories

𝗙𝗼𝗿 𝗠𝗼𝗿𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:

https://www.prnewswire.com/news-releases/non-polar-carotene-derivation-to-position-hexane-market-at-us-3-05-bn-in-2032--301573865.html

https://www.prnewswire.com/news-releases/petroleum-coke-market-demand-to-reach-us-63-10-bn-by-2032-amid-rising-application-in-cement-industry-301575549.html

https://www.prnewswire.com/news-releases/mounting-focus-on-refining-processes-to-steer-glycol-pumps-market-past-us-224-3-mn-in-2032--301576594.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.